Clemens Bos

Dr. Clemens Bos

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2013 in Journal of Therapeutic Ultrasound
Verified
Journal Article
Open access
PDF file
NHNicole M Hijnen
Nicole M Hijnen
AEAaldert Elevelt
Aaldert Elevelt
JPJeroen Pikkemaat
Jeroen Pikkemaat
CBClemens Bos
Clemens Bos
LBLambertus W Bartels
Lambertus W Bartels
HGHolger Gruell
Holger Gruell
Background: Proton resonance frequency shift (PRFS) magnetic resonance (MR) thermometry exploits the local magnetic field changes induced by the temperature dependence of the electron screening constant of water protons. Any other local magnetic field changes will therefore translate into incorrect temperature readings and need to be considered accordingly. Here, we investigated the susceptibility changes induced by the inflow and presence of a paramagnetic MR contrast agent and their implications on PRFS thermometry. Methods: Phantom measurements were performed to demonstrate the effect of sudden gadopentetate dimeglumine (Gd-DTPA) inflow on the phase shift measured using a PRFS thermometry sequence on a clinical 3 T magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) system. By proton nuclear magnetic resonance spectroscopy, the temperature dependence of the Gd-DTPA susceptibility was measured, as well as the effect of liposomal encapsulation and release on the bulk magnetic susceptibility of Gd-DTPA. In vivo studies were carried out to measure the temperature error induced in a rat hind leg muscle upon intravenous Gd-DTPA injection. Results: The phantom study showed a significant phase shift inside the phantom of 0.6 ± 0.2 radians (mean ± standard deviation) upon Gd-DTPA injection (1.0 mM, clinically relevant amount). A Gd-DTPA-induced magnetic susceptibility shift of ΔχGd-DTPA = 0.109 ppm/mM was measured in a cylinder parallel to the main magnetic field at 37°C. The temperature dependence of the susceptibility shift showed dΔχGd-DTPA/dT = -0.00038 ± 0.00008 ppm/mM/°C. No additional susceptibility effect was measured upon Gd release from paramagnetic liposomes. In vivo, intravenous Gd-DTPA injection resulted in a perceived temperature change of 2.0°C ± 0.1°C at the center of the hind leg muscle. Conclusions: The use of a paramagnetic MR contrast agent prior to MR-HIFU treatment may influence the accuracy of the PRFS MR thermometry. Depending on the treatment workflow, Gd-induced temperature errors ranging between -4°C and +3°C can be expected. Longer waiting time between contrast agent injection and treatment, as well as shortening the ablation duration by increasing the sonication power, will minimize the Gd influence. Compensation for the phase changes induced by the changing Gd presence is difficult as the magnetic field changes are arising nonlocally in the surroundings of the susceptibility change.

27 May 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
NWNicole Willems
Nicole Willems
FBFrances C Bach
Frances C Bach
SPSaskia G M Plomp
Saskia G M Plomp
MRMattie Hp van Rijen
Mattie Hp van Rijen
JWJeannette Wolfswinkel
Jeannette Wolfswinkel
MTMarianna Tryfonidou
Marianna Tryfonidou
Strategies for biological repair and regeneration of the intervertebral disc (IVD) by cell and tissue engineering are promising, but few have made it into a clinical setting. Recombinant human bone morphogenetic protein 7 (rhBMP-7) has been shown to stimulate matrix production by IVD cells in vitro and in vivo in animal models of induced IVD degeneration. The aim of this study was to determine the most effective dose of an intradiscal injection of rhBMP-7 in a spontaneous canine IVD degeneration model for translation into clinical application for patients with low back pain. Canine nucleus pulposus cells (NPCs) were cultured with rhBMP-7 to assess the anabolic effect of rhBMP-7 in vitro, and samples were evaluated for glycosaminoglycan (GAG) and DNA content, histology, and matrix-related gene expression. Three different dosages of rhBMP-7 (2.5 μg, 25 μg, and 250 μg) were injected in vivo into early degenerated IVDs of canines, which were followed up for six months by magnetic resonance imaging (T2-weighted images, T1rho and T2 maps). Post-mortem, the effects of rhBMP-7 were determined by radiography, computed tomography, and macroscopy, and by histological, biochemical (GAG, DNA, and collagen), and biomolecular analyses of IVD tissue. In vitro, rhBMP-7 stimulated matrix production of canine NPCs as GAG deposition was enhanced, DNA content was maintained, and gene expression levels of ACAN and COL2A1 were significantly upregulated. Despite the wide dose range of rhBMP-7 (2.5 to 250 μg) administered in vivo, no regenerative effects were observed at the IVD level. Instead, extensive extradiscal bone formation was noticed after intradiscal injection of 25 μg and 250 μg of rhBMP-7. An intradiscal bolus injection of 2.5 μg, 25 μg, and 250 μg rhBMP-7 showed no regenerative effects in a spontaneous canine IVD degeneration model. In contrast, intradiscal injection of 250 μg rhBMP-7, and to a lesser extent 25 μg rhBMP-7, resulted in extensive extradiscal bone formation, indicating that a bolus injection of rhBMP-7 alone cannot be used for treatment of IVD degeneration in human or canine patients.

Verified
Journal Article
Open access
PDF file
YYYuana Yuana
Yuana Yuana
LJLinglei Jiang
Linglei Jiang
BLBart H. A. Lammertink
Bart H. A. Lammertink
PVPieter Vader
Pieter Vader
RDRoel Deckers
Roel Deckers
CMChrit T. Moonen
Chrit T. Moonen
Microbubbles-assisted ultrasound (USMB) has shown promise in improving local drug delivery. The formation of transient membrane pores and endocytosis are reported to be enhanced by USMB, and they contribute to cellular drug uptake. Exocytosis also seems to be linked to endocytosis upon USMB treatment. Based on this rationale, we investigated whether USMB triggers exocytosis resulting in the release of extracellular vesicles (EVs). USMB was performed on a monolayer of head-and-neck cancer cells (FaDu) with clinically approved microbubbles and commonly used ultrasound parameters. At 2, 4, and 24 h, cells and EV-containing conditioned media from USMB and control conditions (untreated cells, cells treated with microbubbles and ultrasound only) were harvested. EVs were measured using flow cytometric immuno-magnetic bead capture assay, immunogold electron microscopy, and western blotting. After USMB, levels of CD9 exposing-EVs significantly increased at 2 and 4 h, whereas levels of CD63 exposing-EVs increased at 2 h. At 24 h, EV levels were comparable to control levels. EVs released after USMB displayed a heterogeneous size distribution profile (30–1200 nm). Typical EV markers CD9, CD63, and alix were enriched in EVs released from USMB-treated FaDu cells. In conclusion, USMB treatment triggers exocytosis leading to the release of EVs from FaDu cells.

9 October 2019 in Cancers
Verified
Journal Article
Open access
PDF file
HBHelena Besse
Helena Besse
ARAngelique D. Barten-Van Rijbroek
Angelique D. Barten-Van Rijbroek
KWKim M.G. van der Wurff-Jacobs
Kim M.G. van der Wurff-Jacobs
CBClemens Bos
Clemens Bos
CMChrit T.W. Moonen
Chrit T.W. Moonen
RDRoel Deckers
Roel Deckers
Tumor drug distribution and concentration are important factors for effective tumor treatment. A promising method to enhance the distribution and the concentration of the drug in the tumor is to encapsulate the drug in a temperature sensitive liposome. The aim of this study was to investigate the tumor drug distribution after treatment with various injected doses of different liposomal formulations of doxorubicin, ThermoDox (temperature sensitive liposomes) and DOXIL (non-temperature sensitive liposomes), and free doxorubicin at macroscopic and microscopic levels. Only ThermoDox treatment was combined with hyperthermia. Experiments were performed in mice bearing a human fibrosarcoma. At low and intermediate doses, the largest growth delay was obtained with ThermoDox, and at the largest dose, the largest growth delay was obtained with DOXIL. On histology, tumor areas with increased doxorubicin concentration correlated with decreased cell proliferation, and substantial variations in doxorubicin heterogeneity were observed. ThermoDox treatment resulted in higher tissue drug levels than DOXIL and free doxorubicin for the same dose. A relation with the distance to the vasculature was shown, but vessel perfusion was not always sufficient to determine doxorubicin delivery. Our results indicate that tumor drug distribution is an important factor for effective tumor treatment and that its dependence on delivery formulation merits further systemic investigation.

1 January 2016
Verified
Book Chapter
Closed access
PDF file
Jean-Michel EscoffreJean-Michel Escoffre
Jean-Michel Escoffre
RDRoel Deckers
Roel Deckers
CBClemens Bos
Clemens Bos
CMChrit Moonen
Chrit Moonen

2 July 2001 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
CBClemens Bos
Clemens Bos
CBChris J.G. Bakker
Chris J.G. Bakker
MVMax A. Viergever
Max A. Viergever
In contrast‐enhanced MR projection angiography, vessel conspicuity is determined by the T1‐weighted signal difference between blood and surrounding tissues. For slice‐selective excitation pulses, the excitation angle varies across the slice, leading to poor saturation of the background signal at the slice edge and reducing the blood‐background signal difference. This work reports on the use of magnetization preparation to enhance the T1‐weighted contrast between blood and background tissue. Applying the prepulse nonselectively reduces the influence of the slice profile imperfections of the excitation pulse by keeping the background tissue at the slice edge saturated. Analytical calculations and in vitro experiments show that a prepulse angle of 110°–130° and a delay time of 20–25 ms enhance the contrast between contrast‐enhanced blood (T1 < 50 ms) and background tissues (T1 > 200 ms), and improve the slice weighting profile. Magnetization preparation is shown to effectively suppress signal from background tissue, resulting in a threefold increase of the vessel‐to‐background signal ratio. Magnetization preparation eliminates the need for subtraction at the cost of a slight increase in scan time. Possible applications, such as projection MRA, detection of contrast arrival, and test‐bolus tracking are demonstrated in a pig model. Magn Reson Med 46:78–87, 2001.